https://www.selleckchem.com/pr....oducts/cdk2-inhibito
To detect the potential of microRNA-492 (miR-492) as a diagnostic biomarker of acute myocardial infarction (AMI) in the acute phase. A total of 100 AMI patients and 100 controls (non-AMI patients with chest pain) were retrospectively analyzed. Blood samples were collected at 0, 6, 12, and 24 h after admission, followed by detection of the serum miR-492 level. Serum levels of cTnI and creatine kinase-MB (CK-M in AMI patients were examined by enzyme-linked immunosorbent assay (ELISA). The potential relationship between miR-492
Like
Comment
Share
